Abeona Therapeutics ABEO
NASDAQ ABEO
$6.01 +0.08 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Abeona Therapeutics (ABEO) Raw Materials (2025 - 2026)

Abeona Therapeutics (ABEO) posted quarterly Raw Materials of $5.5 million for Q1 2026, little changed quarter-over-quarter from $5.5 million in Q4 2025.

Analysis

Abeona Therapeutics (ABEO) Raw Materials (2025 - 2026) Analysis & Trends

Abeona Therapeutics' Raw Materials history runs 2 years deep, the most recent figure standing at $5.5 million for Q1 2026.

  • In Q1 2026, Raw Materials changed N/A year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $5.5 million (changed N/A YoY), while the FY2025 annual figure was $5.5 million, changed N/A from the prior year.
  • Raw Materials for Q1 2026 stood at $5.5 million, roughly flat from $5.5 million in the prior quarter.
  • The five-year high for Raw Materials was $5.5 million in Q1 2026, with the low at $5.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Abeona Therapeutics 342.29 Mn 195.46 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.28 Mn
Mar 31, 2026 5.50 Mn
Dec 31, 2025 5.49 Mn